<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <title>Collective Insight Lab Report</title>
  </head>
  <body>
    <h1>Collective Insight Lab</h1>
    <section>
      <h2>Insights</h2>
      <section class='insight'><h3>i0001 · Confidence 0.65</h3><p>Current Progress • Strategy : − Our initial development has focused on building and validating the project&#x27;s technical foundation. Method RCM SA SAL mAP Base (AT [72]) 30.4 + SA ✓ ✓ 41.8 + SAL ✓ ✓ 44.2 GT (Full) ✓ ✓ ✓ 50.8 Table 6: Ablation studies on GT components.</p><p class='provenance'><strong>Provenance:</strong> MR_NeuroReach_VR_Midterm_Presentation_Purkayastha_Elsig_Flueckiger_Khoshimov (1) p3, SFDA_Grounded_Teacher__Rebuttal_ (1) p13</p></section>
<section class='insight'><h3>i0002 · Confidence 0.65</h3><p>RCM is included in all studies as it forms the basis of CRA and SAL. We report the mean average precision at 0.50 IoU (mAP).</p><p class='provenance'><strong>Provenance:</strong> SFDA_Grounded_Teacher__Rebuttal_ (1) p13, SFDA_Grounded_Teacher__Rebuttal_ (1) p13</p></section>
<section class='insight'><h3>i0003 · Confidence 0.65</h3><p>Our contributions are not included in the base framework (AT [71]).</p><p class='provenance'><strong>Provenance:</strong> SFDA_Grounded_Teacher__Rebuttal_ (1) p13</p></section>
    </section>
    <section>
      <h2>Claims Summary</h2>
      <table border="1" cellpadding="8" cellspacing="0">
        <thead>
          <tr>
            <th>ID</th>
            <th>Text</th>
            <th>Verdict</th>
            <th>Notes</th>
            <th>Citation</th>
          </tr>
        </thead>
        <tbody>
          <tr><td>c0001</td><td>Current Progress • Strategy : − Our initial development has focused on building and validating the project&#x27;s technical foundation.</td><td>Supported</td><td>All citations verified</td><td>MR_NeuroReach_VR_Midterm_Presentation_Purkayastha_Elsig_Flueckiger_Khoshimov (1) p3</td></tr>
<tr><td>c0002</td><td>− We have successfully implemented a vertical slice that − Integrates all core hardware and software − Creating a stable platform for the rapid development of our rehabilitation tasks • Validated Integrations: − Establish Pipeline: Successfully setting up pipeline to deploy a Unity build on the Quest 3 ✓ − Passthrough Environment: Successfully merged user real-world space with interactive virtual content ✓ − Spatial Anchors: Pinning virtual objects to the real world ✓ − MX Ink Integration: Real-time tracking of the stylus input ✓ NeuroReach VR 03.11.2025 3.</td><td>Contradicted</td><td>Quote not found near cited span</td><td>MR_NeuroReach_VR_Midterm_Presentation_Purkayastha_Elsig_Flueckiger_Khoshimov (1) p3</td></tr>
<tr><td>c0003</td><td>Method RCM SA SAL mAP Base (AT [72]) 30.4 + SA ✓ ✓ 41.8 + SAL ✓ ✓ 44.2 GT (Full) ✓ ✓ ✓ 50.8 Table 6: Ablation studies on GT components.</td><td>Supported</td><td>All citations verified</td><td>SFDA_Grounded_Teacher__Rebuttal_ (1) p13</td></tr>
<tr><td>c0004</td><td>RCM is included in all studies as it forms the basis of CRA and SAL.</td><td>Supported</td><td>All citations verified</td><td>SFDA_Grounded_Teacher__Rebuttal_ (1) p13</td></tr>
<tr><td>c0005</td><td>We report the mean average precision at 0.50 IoU (mAP).</td><td>Supported</td><td>All citations verified</td><td>SFDA_Grounded_Teacher__Rebuttal_ (1) p13</td></tr>
<tr><td>c0006</td><td>Our contributions are not included in the base framework (AT [71]).</td><td>Supported</td><td>All citations verified</td><td>SFDA_Grounded_Teacher__Rebuttal_ (1) p13</td></tr>
<tr><td>c0007</td><td>5.3 Ablation Studies To verify the significance of our contributions, we conducted an ablation study.</td><td>Contradicted</td><td>Quote not found near cited span</td><td>SFDA_Grounded_Teacher__Rebuttal_ (1) p13</td></tr>
        </tbody>
      </table>
    </section>
  </body>
</html>
